1 | patient instructions for use | | | | | | | 4 | 0.32% |
2 | instructions for use on | | | | | | | 4 | 0.32% |
3 | hcp instructions for use | | | | | | | 4 | 0.32% |
4 | right away if you | | | | | | | 4 | 0.32% |
5 | call your healthcare provider | | | | | | | 4 | 0.32% |
6 | onbody injector patient instructions | | | | | | | 3 | 0.24% |
7 | injector patient instructions for | | | | | | | 3 | 0.24% |
8 | your healthcare provider if | | | | | | | 3 | 0.24% |
9 | healthcare provider if you | | | | | | | 3 | 0.24% |
10 | if you have a | | | | | | | 3 | 0.24% |
11 | body injector patient instructions | | | | | | | 3 | 0.24% |
12 | onpro® kit hcp instructions | | | | | | | 3 | 0.24% |
13 | medical help right away | | | | | | | 3 | 0.24% |
14 | kit hcp instructions for | | | | | | | 3 | 0.24% |
15 | during treatment with neulasta® | | | | | | | 3 | 0.24% |
16 | neulasta® tell your healthcare | | | | | | | 3 | 0.24% |
17 | have a sickle cell | | | | | | | 3 | 0.24% |
18 | healthcare provider about all | | | | | | | 3 | 0.24% |
19 | tell your healthcare provider | | | | | | | 3 | 0.24% |
20 | side effects of neulasta® | | | | | | | 2 | 0.16% |
21 | used to help reduce | | | | | | | 2 | 0.16% |
22 | to help reduce the | | | | | | | 2 | 0.16% |
23 | low white blood cell | | | | | | | 2 | 0.16% |
24 | inflammation of the aorta | | | | | | | 2 | 0.16% |
25 | syringe instructions for use | | | | | | | 2 | 0.16% |
26 | ml in a singledose | | | | | | | 2 | 0.16% |
27 | for use onbody injector | | | | | | | 2 | 0.16% |
28 | mg06 ml in a | | | | | | | 2 | 0.16% |
29 | prefilled syringe instructions for | | | | | | | 2 | 0.16% |
30 | use prefilled syringe instructions | | | | | | | 2 | 0.16% |
31 | 6 mg06 ml in | | | | | | | 2 | 0.16% |
32 | for use prefilled syringe | | | | | | | 2 | 0.16% |
33 | instructions for use prefilled | | | | | | | 2 | 0.16% |
34 | injection 6 mg06 ml | | | | | | | 2 | 0.16% |
35 | will check your blood | | | | | | | 2 | 0.16% |
36 | neulasta® injection 6 mg06 | | | | | | | 2 | 0.16% |
37 | use onbody injector patient | | | | | | | 2 | 0.16% |
38 | develop any of the | | | | | | | 2 | 0.16% |
39 | provider will check your | | | | | | | 2 | 0.16% |
40 | healthcare provider right away | | | | | | | 2 | 0.16% |